Skip to main content
Top
Published in: BMC Pulmonary Medicine 1/2023

Open Access 01-12-2023 | Bronchial Asthma | Research

Anticipating undiagnosed asthma in symptomatic adults with normal pre- and post-bronchodilator spirometry: a decision tool for bronchial challenge testing

Authors: Sheojung Shin, George Alex Whitmore, Louis-Philippe Boulet, Marie-Ève Boulay, Andréanne Côté, Céline Bergeron, Catherine Lemière, M. Diane Lougheed, Katherine L. Vandemheen, Gonzalo G. Alvarez, Sunita Mulpuru, Shawn D. Aaron

Published in: BMC Pulmonary Medicine | Issue 1/2023

Login to get access

Abstract

Background

Some patients with asthma demonstrate normal spirometry and remain undiagnosed without further testing.

Objective

To determine clinical predictors of asthma in symptomatic adults with normal spirometry, and to generate a tool to help clinicians decide who should undergo bronchial challenge testing (BCT).

Methods

Using random-digit dialling and population-based case-finding, we recruited adults from the community with respiratory symptoms and no previous history of diagnosed lung disease. Participants with normal pre- and post-bronchodilator spirometry subsequently underwent BCT. Asthma was diagnosed in those with symptoms and a methacholine provocative concentration (PC20) of < 8 mg/ml. Sputum and blood eosinophils, and exhaled nitric oxide were measured. Univariate analyses identified potentially predictive variables, which were then used to construct a multivariable logistic regression model to predict asthma. Model sensitivity, specificity, and area under the receiver operating curve (AUC) were calculated.

Results

Of 132 symptomatic individuals with normal spirometry, 34 (26%) had asthma. Of those ultimately diagnosed with asthma, 33 (97%) answered ‘yes’ to a question asking whether they experienced cough, chest tightness or wheezing provoked by exercise or cold air. Other univariate predictors of asthma included female sex, pre-bronchodilator FEV1 percentage predicted, and percent positive change in FEV1 post bronchodilator. A multivariable model containing these predictive variables yielded an AUC of 0.82 (95% CI: 0.72–0.91), a sensitivity of 82%, and a specificity of 66%. The model was used to construct a nomogram to advise clinicians which patients should be prioritized for BCT.

Conclusions

Four readily available patient characteristics demonstrated a high sensitivity and AUC for predicting undiagnosed asthma in symptomatic adults with normal pre- and post-bronchodilator spirometry. These characteristics can potentially help clinicians to decide which individuals with normal spirometry should be investigated with bronchial challenge testing. However, further prospective validation of our decision tool is required.
Appendix
Available only for authorised users
Literature
1.
go back to reference Vos T, Lim SS, Abbafati C, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the global burden of disease study 2019. Lancet. 2020;396:1204–22.CrossRef Vos T, Lim SS, Abbafati C, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the global burden of disease study 2019. Lancet. 2020;396:1204–22.CrossRef
2.
go back to reference Nurmagambetov T, Kuwahara R, Garbe P. The economic burden of asthma in the United States, 2008-2013. Ann Am Thorac Soc. 2018;15(3):348–56.CrossRefPubMed Nurmagambetov T, Kuwahara R, Garbe P. The economic burden of asthma in the United States, 2008-2013. Ann Am Thorac Soc. 2018;15(3):348–56.CrossRefPubMed
3.
go back to reference Aaron SD, Vandemheen KL, FitzGerald JM, et al. Canadian respiratory research network. Reevaluation of diagnosis in adults with physician-diagnosed asthma. JAMA. 2017;317:269–79.CrossRefPubMed Aaron SD, Vandemheen KL, FitzGerald JM, et al. Canadian respiratory research network. Reevaluation of diagnosis in adults with physician-diagnosed asthma. JAMA. 2017;317:269–79.CrossRefPubMed
4.
go back to reference Aaron SD, Boulet LP, Reddel HK, Gershon AS. Underdiagnosis and Overdiagnosis of asthma. Am J Respir Crit Care Med. 2018;198(8):1012–20.CrossRefPubMed Aaron SD, Boulet LP, Reddel HK, Gershon AS. Underdiagnosis and Overdiagnosis of asthma. Am J Respir Crit Care Med. 2018;198(8):1012–20.CrossRefPubMed
8.
go back to reference Pepys J, Hutchcroft BJ. Bronchial provocation tests in etiologic diagnosis and analysis of asthma. Am Rev Respir Dis. 1975;112(6):829–59.PubMed Pepys J, Hutchcroft BJ. Bronchial provocation tests in etiologic diagnosis and analysis of asthma. Am Rev Respir Dis. 1975;112(6):829–59.PubMed
9.
go back to reference Crapo R, Casaburi R, Coates A, et al. Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of directors, July 1999. Am J Respir Crit Care Med. 2000;161(1):309–29.CrossRefPubMed Crapo R, Casaburi R, Coates A, et al. Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of directors, July 1999. Am J Respir Crit Care Med. 2000;161(1):309–29.CrossRefPubMed
10.
go back to reference Perpiñá M, Pellicer C, de Diego A, Compte L, Macián V. Diagnostic value of the bronchial provocation test with methacholine in asthma. A Bayesian analysis approach. Chest. 1993;104(1):149–54.CrossRefPubMed Perpiñá M, Pellicer C, de Diego A, Compte L, Macián V. Diagnostic value of the bronchial provocation test with methacholine in asthma. A Bayesian analysis approach. Chest. 1993;104(1):149–54.CrossRefPubMed
11.
go back to reference Dales RE, Nunes F, Partyka D, Ernst P. Clinical prediction of airways hyperresponsiveness. Chest. 1988;93(5):984–6.CrossRefPubMed Dales RE, Nunes F, Partyka D, Ernst P. Clinical prediction of airways hyperresponsiveness. Chest. 1988;93(5):984–6.CrossRefPubMed
17.
go back to reference Preteroti M, Whitmore GA, Vandemheen KL, et al. Population-based case-finding to identify subjects with undiagnosed asthma or COPD. Eur Respir J. 2020;55(6):2000024.CrossRefPubMed Preteroti M, Whitmore GA, Vandemheen KL, et al. Population-based case-finding to identify subjects with undiagnosed asthma or COPD. Eur Respir J. 2020;55(6):2000024.CrossRefPubMed
19.
go back to reference Shin B, Cole SL, Park SJ, Ledford DK, Lockey RF. A new symptom-based questionnaire for predicting the presence of asthma. J Investig Allergol Clin Immunol. 2010;20(1):27–34.PubMed Shin B, Cole SL, Park SJ, Ledford DK, Lockey RF. A new symptom-based questionnaire for predicting the presence of asthma. J Investig Allergol Clin Immunol. 2010;20(1):27–34.PubMed
20.
go back to reference Price DB, Tinkelman DG, Halbert RJ, et al. Symptom-based questionnaire for identifying chronic obstructive pulmonary disease in smokers. Respiration. 2006;73:285–95.CrossRefPubMed Price DB, Tinkelman DG, Halbert RJ, et al. Symptom-based questionnaire for identifying chronic obstructive pulmonary disease in smokers. Respiration. 2006;73:285–95.CrossRefPubMed
21.
go back to reference Hallstrand TS, Leuppi JD, Joos G, et al. American Thoracic Society (ATS)/European Respiratory Society (ERS) Bronchoprovocation testing task force. ERS technical standard on bronchial challenge testing: pathophysiology and methodology of indirect airway challenge testing. Eur Respir J. 2018;52(5) Hallstrand TS, Leuppi JD, Joos G, et al. American Thoracic Society (ATS)/European Respiratory Society (ERS) Bronchoprovocation testing task force. ERS technical standard on bronchial challenge testing: pathophysiology and methodology of indirect airway challenge testing. Eur Respir J. 2018;52(5)
22.
go back to reference Coates AL, Wanger J, Cockcroft DW, et al. ERS technical standard on bronchial challenge testing: general considerations and performance of methacholine challenge tests. Eur Respir J. 2017;49(5):1601526.CrossRefPubMed Coates AL, Wanger J, Cockcroft DW, et al. ERS technical standard on bronchial challenge testing: general considerations and performance of methacholine challenge tests. Eur Respir J. 2017;49(5):1601526.CrossRefPubMed
23.
go back to reference Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline LN. Development and first validation of the COPD assessment test. Eur Respir J. 2009;34(3):648–54.CrossRefPubMed Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline LN. Development and first validation of the COPD assessment test. Eur Respir J. 2009;34(3):648–54.CrossRefPubMed
25.
go back to reference Juniper EF, O'Byrne PM, Guyatt GH, Ferrie PJ, King DR. Development and validation of a questionnaire to measure asthma control. Eur Respir J. 1999;14(4):902–7.CrossRefPubMed Juniper EF, O'Byrne PM, Guyatt GH, Ferrie PJ, King DR. Development and validation of a questionnaire to measure asthma control. Eur Respir J. 1999;14(4):902–7.CrossRefPubMed
26.
go back to reference Birring SS, Prudon B, Carr AJ, Singh SJ, Morgan MD, Pavord ID. Development of a symptom specific health status measure for patients with chronic cough: Leicester cough questionnaire (LCQ). Thorax. 2003;58:339–43.CrossRefPubMedPubMedCentral Birring SS, Prudon B, Carr AJ, Singh SJ, Morgan MD, Pavord ID. Development of a symptom specific health status measure for patients with chronic cough: Leicester cough questionnaire (LCQ). Thorax. 2003;58:339–43.CrossRefPubMedPubMedCentral
27.
go back to reference Burney PG, Luczynska C, Chinn S, Jarvis D. The European Community respiratory health survey. Eur Res J. 1994;7(5):954–60.CrossRef Burney PG, Luczynska C, Chinn S, Jarvis D. The European Community respiratory health survey. Eur Res J. 1994;7(5):954–60.CrossRef
28.
go back to reference Pizzichini E, Pizzichini MM, Efthimiadis A, Hargreave FE, Dolovich J. Measurement of inflammatory indices in induced sputum: effects of selection of sputum to minimize salivary contamination. Eur Respir J. 1996;9:1174–80.CrossRefPubMed Pizzichini E, Pizzichini MM, Efthimiadis A, Hargreave FE, Dolovich J. Measurement of inflammatory indices in induced sputum: effects of selection of sputum to minimize salivary contamination. Eur Respir J. 1996;9:1174–80.CrossRefPubMed
29.
go back to reference Dweik RA, Boggs PB, Erzurum SC, et al. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med. 2011;184:602–15.CrossRefPubMedPubMedCentral Dweik RA, Boggs PB, Erzurum SC, et al. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med. 2011;184:602–15.CrossRefPubMedPubMedCentral
30.
go back to reference Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J. 2005;26:319–38.CrossRefPubMed Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J. 2005;26:319–38.CrossRefPubMed
31.
go back to reference Quanjer PH, Stanojevic S, Cole TJ, et al. Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. Eur Respir J. 2012;40:1324–43.CrossRefPubMedPubMedCentral Quanjer PH, Stanojevic S, Cole TJ, et al. Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. Eur Respir J. 2012;40:1324–43.CrossRefPubMedPubMedCentral
35.
go back to reference Chung KF, Wenzel SE, Brozek JL, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J. 2014;43(2):343–73.CrossRefPubMed Chung KF, Wenzel SE, Brozek JL, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J. 2014;43(2):343–73.CrossRefPubMed
39.
go back to reference Reddel HK, Busse WW, Pedersen S, et al. Should recommendations about starting inhaled corticosteroid treatment for mild asthma be based on symptom frequency: a post-hoc efficacy analysis of the START study. Lancet. 2017;389:157–66.CrossRefPubMed Reddel HK, Busse WW, Pedersen S, et al. Should recommendations about starting inhaled corticosteroid treatment for mild asthma be based on symptom frequency: a post-hoc efficacy analysis of the START study. Lancet. 2017;389:157–66.CrossRefPubMed
40.
go back to reference Haahtela T, Jarvinen M, Kava T, et al. Comparison of a beta 2- agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma. N Engl J Med. 1991;325:388–92.CrossRefPubMed Haahtela T, Jarvinen M, Kava T, et al. Comparison of a beta 2- agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma. N Engl J Med. 1991;325:388–92.CrossRefPubMed
51.
go back to reference Kanner RE, Connett JE, Altose MD, et al. Gender difference in airway hyperresponsiveness in smokers with mild COPD. The lung health study. Am J Respir Crit Care Med. 1994;150(4):956–61.CrossRefPubMed Kanner RE, Connett JE, Altose MD, et al. Gender difference in airway hyperresponsiveness in smokers with mild COPD. The lung health study. Am J Respir Crit Care Med. 1994;150(4):956–61.CrossRefPubMed
52.
go back to reference Leynaert B, Bousquet J, Henry C, Liard R, Neukirch F. Is bronchial hyperresponsiveness more frequent in women than in men? A population-based study. Am J Respir Crit Care Med. 1997;156(5):1413–20.CrossRefPubMed Leynaert B, Bousquet J, Henry C, Liard R, Neukirch F. Is bronchial hyperresponsiveness more frequent in women than in men? A population-based study. Am J Respir Crit Care Med. 1997;156(5):1413–20.CrossRefPubMed
Metadata
Title
Anticipating undiagnosed asthma in symptomatic adults with normal pre- and post-bronchodilator spirometry: a decision tool for bronchial challenge testing
Authors
Sheojung Shin
George Alex Whitmore
Louis-Philippe Boulet
Marie-Ève Boulay
Andréanne Côté
Céline Bergeron
Catherine Lemière
M. Diane Lougheed
Katherine L. Vandemheen
Gonzalo G. Alvarez
Sunita Mulpuru
Shawn D. Aaron
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Pulmonary Medicine / Issue 1/2023
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/s12890-023-02806-9

Other articles of this Issue 1/2023

BMC Pulmonary Medicine 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.